Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy

Archives of General Psychiatry

Volumn 53, Issue 5, 1996, Pages 409-415

  Silverman, Kenneth ^a,b   Higgins, Stephen T ^c   Brooner, Robert K ^b   Montoya, Ivan D ^a,d   Cone, Edward J ^a   Schuster, Charles R ^a,e   Preston, Kenzie L ^a,b,f  

^a NIDA Addiction Research Center   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^e WAYNE STATE UNIVERSITY   (United States)

^f NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; METHADONE;

ABSTINENCE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DEPENDENCE; HUMAN; HUMAN TISSUE; METHADONE TREATMENT; RANDOMIZED CONTROLLED TRIAL; REINFORCEMENT; TREATMENT OUTCOME; TREATMENT PLANNING; URINALYSIS;

EID: 0029936433     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1996.01830050045007     Document Type: Article

References (34)

1. Friedman SR, Lipton DS, Stimel B. Cocaine, AIDS, and Intravenous Drug Use. New York, NY: Harringion Park Press; 1991:1-11
2. Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 1989; 261:561-565.
3. De La Rosa M, Lambert EY, Gropper B, eds. Drugs and Violence: Causes, Correlates, and Consequences Washington, DC. US Government Printing Office; 1990. NIDA Research Monograph 103.
4. Drug Abuse: The Crack Cocaine Epidemic: Health Consequences and Treatment. Washington, DC; General Accounting Office: 1991 GAO/HRD-91-55FS.
5. Johanson CE, Schuster CR. Cocaine. In: DJ Kupfer, FE Bloom, eds Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995 1685-1697.
6. Gorelick DA. Pharmacologic therapies for cocaine addiction. In: Miller NS, Gold M, eds. Pharmacological Therapies for Alcohol and Drug Addictions. New York, NY. Marcel Dekker Inc, 1994:143-157.
7. Rawson RA, Obert JL, McCann MJ, Castro FG, Ling W. Cocaine abuse treatment: a review of current strategies. J Subst Abuse. 1991;3:457-491.
8. Rawson RA, McCann MJ, Hasson AJ, Ling W. Cocaine abuse among methadone patients: are there effective treatment strategies? J Psychoactive Drugs. 1994;26:129-136.
9. Stitzer ML, Higgins ST. Behavioral treatment of drug and alcohol abuse. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY Raven Press; 1995:1807-1819.
10. Stitzer ML, Bigelow GE, Gross J. Behavioral treatments of drug abuse. In: Treatments of Psychiatric Disorders: A Task Force Report of the American Psychiatric Association Washington, DC American Psychiatric Association, 1989;2: 1430-1448.
11. Higgins ST, Delaney DD, Budney AJ, Bickel WK, Hughes JR, Feorg F, Fenwick JW A behavioral approach to achieving initial cocaine abstinence. Am J Psychiatry. 1991,148:1218-1224.
12. Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg F, Badger GJ. Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry. 1993;150. 763-769
13. Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry 1994,51 568-576.
14. Kosten TR, Gawin FH, Rounsaville BJ, Kleber HD. Cocaine abuse among opioid addicts demographic and diagnostic factors in treatment. Am J Drug Alcohol Abuse 1986;12:1-16.
15. Hanbury R, Sturiano V, Cohen M, Stimmel B, Aguillaume C. Cocaine use in persons on methadone maintenance. Adv Alcohol Subst Abuse. 1986:6:91-106.
16. Condelli WS, Fairbank JA, Dennis ML, Rachal JV. Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions. J Subst Abuse Treat. 1991;8:203-212.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
18. McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, O'Brien CP. New data from the Addiction Severity Index: reliability and validity in three centers J Nerv Ment Dis. 1985;173 412-423.
19. Robins LN, Heizer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psychiatry. 1981;38:381-389.
20. Beck AT, Steer RA. Beck Depression Inventory Manual New York, NY: Psychological Corp; 1987.
21. Derogatis LR. SCL-90-R Administration, Scoring & Procedures Manual-II for the Revised Version Towson, Md. Clinical Psychometric Research, 1977.
22. Zachary RA. Shipley Institute of Living Scale, Revised Manual. Los Angeles, Calif: Western Psychological Services; 1986.
23. D'Aunno T, Vaughn TE Variations in methadone treatment practices: results from a national study. JAMA 1992,267 253-258
24. Cone EJ, Menchen SL, Mitchell J. Validity testing of the TDX cocaine metabolite assay with human specimens obtained after intravenous cocaine administration. Forensic Sci Int. 1988;37:265-275.
25. Aickin M. A program for balancing the allocation of subjects in a clinical trial. Comput Biomed fies 1982:15:519-524.
26. Huynh H, Feldt LS. Estimation of the Box correction for degrees of freedom from sample data in randomized-block and split-plot designs. J Educ Stat. 1976; 1.69-82.
27. Keppel G. Design and Analysis: A Researcher's Handbook. 2nd ed Englewood Cliffs, NJ Prentice-Hall Inc. 1982:146-150.
28. Bruning JL, Kintz BL Computational Handbook of Statistics 2nd ed. Glenview, III: Scott Foresman & Co; 1977:113-116.
29. Sherman MF, Bigelow GE. Validity of patients' self-reported drug use as a function of treatment status Drug Alcohol Depend 1992:30:1-11.
30. Higgins ST, Budney AJ, Bickel WK, Badger GJ, Foerg FE, Ogden D. Outpatient behavioral treatment for cocaine dependence: one-year outcome Exp Clin Psychopharmacol. 1995;3:205-212.
31. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin F. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence, delayed emergence of psychotherapy effects. Arch Gen Psychiatry. 1994;51.989-997.
32. Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry. 1989,46:117-121.
33. Friedlander D, Ricco J, Freedman S. GAIN: Two-Year impacts in Six Counties: California's Greater Avenues for Independence Program. New York, NY: Manpower Demonstration Research Corp; 1993
34. Shaner AE, Eckman TT, Roberts LJ, Wilkens JN, Tucker DE, Tsuang JW, Mintz J. Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers. W Engl J Med. 1995;333;777-783.